Alpha Teknova, Inc. (TKNO)
NASDAQ: TKNO · Real-Time Price · USD
2.880
-0.130 (-4.32%)
At close: Mar 17, 2026, 4:00 PM EDT
2.830
-0.050 (-1.74%)
After-hours: Mar 17, 2026, 4:46 PM EDT
Alpha Teknova Market Cap
Alpha Teknova has a market cap or net worth of $154.33 million as of March 17, 2026. Its market cap has decreased by -55.46% in one year.
Market Cap
154.33M
Enterprise Value
161.26M
1-Year Change
-55.46%
Ranking
Category
Stock Price
$2.88
Market Cap Chart
Since the IPO on June 25, 2021, Alpha Teknova's market cap has decreased from $433.79M to $154.33M, a decrease of -64.42%. That is a compound annual growth rate of -19.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 161.30M | -20.70% |
| Dec 31, 2025 | 203.41M | -54.30% |
| Dec 31, 2024 | 445.12M | 193.01% |
| Dec 29, 2023 | 151.91M | -4.25% |
| Dec 30, 2022 | 158.66M | -72.34% |
| Dec 31, 2021 | 573.68M | 32.25% |
| Jun 25, 2021 | 433.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Organogenesis Holdings | 331.89M |
| Evolus | 327.90M |
| China SXT Pharmaceuticals | 206.53M |
| Journey Medical | 202.16M |
| Aurora Cannabis | 196.82M |
| Organigram Global | 194.25M |
| Anika Therapeutics | 192.43M |
| Lifecore Biomedical | 163.54M |